Maternal Mental Health

Global Maternal Mental Health Market to Reach US$39.8 Billion by 2030

The global market for Maternal Mental Health estimated at US$9.9 Billion in the year 2024, is expected to reach US$39.8 Billion by 2030, growing at a CAGR of 26.0% over the analysis period 2024-2030. Postpartum Depression Disease Indication, one of the segments analyzed in the report, is expected to record a 23.6% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the Dysthymia Disease Indication segment is estimated at 29.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 33.8% CAGR

The Maternal Mental Health market in the U.S. is estimated at US$2.7 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.6 Billion by the year 2030 trailing a CAGR of 33.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.2% and 23.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 21.8% CAGR.

Global Maternal Mental Health Market – Key Trends & Drivers Summarized

Why Is Maternal Mental Health Finally Receiving the Attention It Deserves?

Maternal mental health is rapidly gaining recognition as a vital component of global public health, moving beyond its once-muted position to the forefront of healthcare conversations. Increased awareness around postpartum depression, perinatal anxiety, and mood disorders during and after pregnancy has led to growing advocacy and policy focus. For decades, maternal mental health issues were underdiagnosed and undertreated due to social stigma, limited screening protocols, and a lack of integrated care frameworks. Today, growing scientific evidence and public discourse are highlighting the profound impact maternal mental health can have not only on mothers but also on infant development, partner dynamics, and family wellbeing. The stressors of modern motherhood—ranging from economic insecurity and social isolation to medical complications and sleep deprivation—are intensifying the mental health burden among new mothers. The COVID-19 pandemic further exacerbated these challenges, with lockdowns, disrupted healthcare access, and limited support systems significantly increasing maternal distress globally. In response, governments, NGOs, and health institutions are investing in maternal mental health screening programs, educational campaigns, and early intervention strategies. Cultural narratives are also shifting, empowering women to speak openly about their struggles and seek timely care, transforming maternal mental health into a priority within broader women’s health agendas.

How Are Innovations in Digital Health Transforming Maternal Mental Healthcare Delivery?

Technology is playing an instrumental role in reshaping how maternal mental healthcare is delivered, accessed, and scaled. Digital health platforms, including mobile apps, telepsychiatry, and virtual support groups, are bridging care gaps for new and expecting mothers who may lack access to traditional mental health services. AI-powered mental health tools are being developed to monitor behavioral changes, screen for risk factors, and deliver cognitive behavioral therapy (CBT) modules tailored for postpartum and perinatal stages. Mobile-first approaches are particularly effective in rural and underserved regions, where infrastructure and healthcare personnel shortages limit access to in-person services. Wearable technology and health trackers are also emerging as supportive tools, helping monitor sleep patterns, stress levels, and hormonal fluctuations—key indicators of maternal mental health. Moreover, integrated maternal health platforms now offer mental health resources alongside obstetric tracking, creating a more holistic care experience. Virtual consultations with therapists and mental health professionals are reducing stigma and enabling discreet, flexible support for women juggling newborn care and recovery. These innovations are not only enhancing early diagnosis and intervention but also democratizing mental health care, making it more inclusive and responsive to the unique emotional landscape of motherhood.

Is the Evolving Role of Employers, Insurers, and Health Systems Driving Market Expansion?

The maternal mental health ecosystem is being reshaped by an expanding network of stakeholders beyond traditional healthcare providers. Employers are beginning to view maternal mental wellness as a critical component of workforce productivity and retention, prompting the inclusion of postpartum mental health resources in employee assistance programs (EAPs). Corporate wellness platforms now offer new-parent counseling, mindfulness tools, and flexible leave policies that acknowledge the emotional complexities of returning to work after childbirth. Insurers are also taking note—some health plans now reimburse for postpartum therapy, mental health screenings during prenatal visits, and app-based mental wellness subscriptions. Meanwhile, health systems are integrating mental health assessments into standard prenatal and postnatal care pathways, often using standardized tools like the Edinburgh Postnatal Depression Scale (EPDS) during checkups. Multidisciplinary care teams—comprising obstetricians, midwives, therapists, and pediatricians—are creating coordinated care models to identify and address mental health concerns early. Public health initiatives and donor funding are supporting pilot programs that train community health workers in maternal mental health screening, especially in low-resource settings. At the policy level, maternal mental health legislation is being introduced in several countries to ensure universal screening and improve care access. As systemic support increases, demand for scalable solutions—including digital therapeutics, support networks, and culturally adapted mental health services—is accelerating across geographies.

What Are the Core Drivers Powering the Maternal Mental Health Market’s Expansion?

The growth in the maternal mental health market is driven by several factors rooted in evolving healthcare delivery models, shifting societal norms, and technology-driven innovation. Rising awareness of the clinical and social implications of untreated maternal mental health conditions has led to increased investment in early screening and intervention protocols, particularly within maternal and child health programs. The widespread use of digital platforms is expanding access to care, especially among younger, tech-savvy mothers seeking flexible and stigma-free support options. Demographic shifts, such as delayed motherhood and higher rates of high-risk pregnancies, are contributing to increased emotional vulnerability during the perinatal period, thus fueling demand for preventive mental health services. The growing integration of behavioral health into obstetric and pediatric settings is creating structural pathways for continuous mental health monitoring from pregnancy through postpartum. Insurance reforms and employer-backed health initiatives are driving reimbursement and utilization of maternal mental health services across both public and private sectors. Additionally, the increasing availability of culturally sensitive and multilingual content is enabling better outreach among diverse populations. In low- and middle-income countries, donor-led programs and global health partnerships are scaling grassroots interventions and mental health training, expanding market potential beyond developed regions. As the maternal mental health narrative evolves from reactive treatment to proactive wellness, it is creating a sustained and diversified demand for services, technologies, and support ecosystems worldwide.

SCOPE OF STUDY:

The report analyzes the Maternal Mental Health market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Disease Indication (Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication, Other Disease Indications); Therapy (Antidepressants Therapy, Interpersonal Psychotherapy, Cognitive Behavioral Therapy, Other Therapies)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -
  • Ahma & Co Postpartum Retreat
  • Anne Arundel Medical Center Maternal Mental Health
  • BetterHelp
  • COOJ Mental Health Foundation
  • Inova Perinatal Mental Health
  • Mammha
  • Maternal Mental Health Alliance
  • Maternal Mental Health Leadership Alliance
  • MPower Minds
  • MS Chellamuthu Trust & Research Foundation
  • Parivarthan Counselling, Training and Research Centre
  • Policy Center for Maternal Mental Health
  • Postpartum Support International
  • Seleni Institute
  • Tele-MANAS
  • The Live Love Laugh Foundation
  • The Motherhood Group

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Maternal Mental Health – Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Awareness Around Postpartum Depression Throws the Spotlight on Early Detection and Support Services
Global Push for Holistic Maternal Care Strengthens Business Case for Integrated Mental Health Screening
Increased Burden of Stress and Anxiety During Pregnancy Expands Addressable Market Opportunity for Preventive Interventions
Shift Toward Virtual Care Models Spurs Growth in Teletherapy and Digital Counseling for Expecting and New Mothers
Here`s the Story: Social Media and Influencer Advocacy Normalize Conversations Around Maternal Mental Well-Being
Workforce Reentry Pressures and Parental Guilt Drive Demand for Emotional Support and Resilience Programs
Growing Integration of Behavioral Health in OB/GYN Settings Drives Adoption of Routine Mental Health Checkpoints
Here`s How Mobile Health Apps and Digital Journals Empower Self-Monitoring and Early Symptom Reporting
Rising Incidence of Maternal Suicide and Untreated Disorders Propels Policy-Level Intervention and Care Funding
Cultural Shifts and Urban Isolation Accelerate Demand for Community-Based Maternal Support Networks
Adoption of AI-Powered Chatbots and Virtual Companions Creates Scalable, Non-Stigmatizing Mental Health Avenues
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Maternal Mental Health Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Maternal Mental Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Postpartum Depression Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Postpartum Depression Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Postpartum Depression Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Dysthymia Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Dysthymia Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Dysthymia Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Pregnancy & Postpartum General Anxiety Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Pregnancy & Postpartum General Anxiety Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Pregnancy & Postpartum General Anxiety Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Pregnancy & Postpartum OCD Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Pregnancy & Postpartum OCD Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Pregnancy & Postpartum OCD Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Birth-Related PTSD Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Birth-Related PTSD Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Birth-Related PTSD Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Antidepressants Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Antidepressants Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Antidepressants Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Interpersonal Psychotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Interpersonal Psychotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Interpersonal Psychotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Cognitive Behavioral Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Cognitive Behavioral Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Cognitive Behavioral Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 36: USA Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: USA 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: USA Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: USA 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
CANADA
TABLE 41: Canada Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: Canada 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: Canada 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
JAPAN
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 47: Japan Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: Japan 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: Japan 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
CHINA
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 53: China Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: China Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: China 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 56: China Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: China Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: China 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
EUROPE
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 59: Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Maternal Mental Health by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Europe 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Europe 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 65: Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: Europe 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
FRANCE
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 68: France Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: France Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: France 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 71: France Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: France Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: France 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
GERMANY
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 74: Germany Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: Germany Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: Germany 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 77: Germany Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: Germany Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: Germany 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
ITALY
TABLE 80: Italy Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Italy Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: Italy 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 83: Italy Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Italy Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Italy 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
UNITED KINGDOM
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 86: UK Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: UK Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: UK 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 89: UK Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: UK Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: UK 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
SPAIN
TABLE 92: Spain Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Spain Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: Spain 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 95: Spain Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Spain Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: Spain 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
RUSSIA
TABLE 98: Russia Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Russia Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: Russia 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 101: Russia Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Russia Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Russia 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Rest of Europe Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Rest of Europe 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Rest of Europe Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: Rest of Europe 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 111: Asia-Pacific Historic Review for Maternal Mental Health by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: Asia-Pacific 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: Asia-Pacific Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: Asia-Pacific 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: Asia-Pacific Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: Asia-Pacific 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
AUSTRALIA
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 119: Australia Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: Australia Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 121: Australia 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 122: Australia Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: Australia Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 124: Australia 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
INDIA
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 125: India Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: India Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 127: India 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 128: India Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: India Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 130: India 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 131: South Korea Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: South Korea Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 133: South Korea 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 134: South Korea Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: South Korea Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 136: South Korea 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Rest of Asia-Pacific Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Rest of Asia-Pacific Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 142: Rest of Asia-Pacific 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
LATIN AMERICA
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 143: Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 144: Latin America Historic Review for Maternal Mental Health by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 145: Latin America 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 146: Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Latin America Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 148: Latin America 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 149: Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: Latin America Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 151: Latin America 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 152: Argentina Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Argentina Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 154: Argentina 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 155: Argentina Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: Argentina Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 157: Argentina 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
BRAZIL
TABLE 158: Brazil Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 159: Brazil Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 160: Brazil 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 161: Brazil Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: Brazil Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 163: Brazil 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
MEXICO
TABLE 164: Mexico Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: Mexico Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 166: Mexico 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 167: Mexico Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: Mexico Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 169: Mexico 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: Rest of Latin America Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 172: Rest of Latin America 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: Rest of Latin America Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 175: Rest of Latin America 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
MIDDLE EAST
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 176: Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 177: Middle East Historic Review for Maternal Mental Health by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 178: Middle East 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 179: Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: Middle East Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 181: Middle East 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 182: Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: Middle East Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 184: Middle East 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
IRAN
TABLE 185: Iran Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: Iran Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 187: Iran 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 188: Iran Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: Iran Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 190: Iran 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
ISRAEL
TABLE 191: Israel Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: Israel Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 193: Israel 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 194: Israel Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: Israel Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 196: Israel 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 198: Saudi Arabia Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 199: Saudi Arabia 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Saudi Arabia Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 202: Saudi Arabia 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 203: UAE Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 204: UAE Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 205: UAE 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 206: UAE Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 207: UAE Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 208: UAE 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 210: Rest of Middle East Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 211: Rest of Middle East 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 213: Rest of Middle East Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 214: Rest of Middle East 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
AFRICA
Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 215: Africa Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 216: Africa Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 217: Africa 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
TABLE 218: Africa Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 219: Africa Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 220: Africa 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings